Sort
82,697 grants matching “vaccine development”
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
$1,363,549Carlos O Esquivel · Stanford University · U01 · FY2015 · AI
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
$1,363,549Carlos O Esquivel · Stanford University · U01 · FY2013 · AI
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
$1,363,549Carlos O Esquivel · Stanford University · U01 · FY2014 · AI
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
$1,363,549Carlos O Esquivel · Stanford University · U01 · FY2016 · AI
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
$1,363,358Eduardo Vilar Sanchez · University Of Tx Md Anderson Can Ctr · UG1 · FY2023 · CA
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
$1,363,070Shabaana A. Khader · Washington University · R01 · FY2022 · AI
Primate Studies
$1,362,127Preston A Marx · University Of Pennsylvania · P01 · FY2011 · AI
Capturing spatial patterns of new M. tuberculosis infection in Kampala, Uganda
$1,361,742Charles Martyn Bark · Case Western Reserve University · R01 · FY2022 · AI
Highly multiplexed platforms for diagnosis of infection and immunity
$1,361,349W. Ian Lipkin · Columbia University Health Sciences · U19 · FY2014 · AI
Gut Homing Cells in SIV infection
$1,361,119Aftab A. Ansari · Emory University · R01 · FY2014 · AI
International Studies Of Acquired Immune Deficiency Syndrome (AIDS)
$1,361,072Thomas Quinn · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment
$1,360,612Mark Schiffman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach
$1,360,346Tim Alan Ahles · Sloan-Kettering Inst Can Research · U54 · FY2021 · CA
The Neural Basis of the Brain-Body Connection
$1,360,133Peter L Strick · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AT
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,359,788Eric Hunter · Emory University · R01 · FY2007 · AI
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
$1,359,557Christine Marie Durand · Johns Hopkins University · U01 · FY2025 · AI
The Ohio State University AIDS Clinical Trials Unit
$1,359,474Susan L Koletar · Ohio State University · U01 · FY2009 · AI
Core N: Biostatistics and Modeling
$1,358,940Sonia Jain · University Of California, San Diego · P30 · FY2020 · AI
Development of Technologies to Facilitate the Use of and Response to Vaccines
$1,358,731Dan Thomas Stinchcomb · Inviragen, Inc. · N01 · FY2011 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,358,469Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Acute Hepatitis C Infection in Young Injectors
$1,358,160Kimberly Page · University Of New Mexico Health Scis Ctr · R01 · FY2017 · DA
COLUMBIA/ROCKEFELLER CENTER FOR AIDS RESEARCH
$1,358,011Columbia University Health Sciences · P30 · FY2002 · AI
Center for Computational Mass Spectrometry
$1,357,906Pavel A Pevzner · University Of California, San Diego · P41 · FY2014 · GM
PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935.
$1,357,821Debra Kelsh · · N01 · FY2020 · DA
Flavivirus Infections: Pathogenesis and Prevention
$1,357,784Univ Of Massachusetts Med Sch Worcester · P01 · FY2004 · AI